LEPETEGRAVIR

UNII:	U7N3Q737CA
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₁H₁₉F₃N₄O₄
Preferred Substance Name:	LEPETEGRAVIR
InChIKey:	AFHGIULBHAXDDI-WDEREUQCSA-N
GSRS Full Record:	U7N3Q737CA i

2808219-64-7
(10S,13R)-6-hydroxy-10,13-dimethyl-5,8-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-1,2,9-triazatricyclo[7.4.1.02,7]tetradeca-3,6,11-triene-4-carboxamide
(1R,10S,13R)-6-hydroxy-10,13-dimethyl-5,8-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-1,2,9-triazatricyclo[7.4.1.02,7]tetradeca-3,6,11-triene-4-carboxamide
(1R,2R,5S)-8-hydroxy-2,5-dimethyl-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,5,7,9-tetrahydro-1,6-methanopyrido[1,2-b][1,2,5]triazonine-10-carboxamide
(1R,2R,5S,6S)-8-hydroxy-2,5-dimethyl-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-2,5,7,9-tetrahydro-1,6-methanopyrido[1,2-b][1,2,5]triazonine-10-carboxamide
1,6-Methanopyrido[1,2-b][1,2,5]triazonine-10-carboxamide, 2,5,7,9-tetrahydro-8-hydroxy-2,5-dimethyl-7,9-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-, (1R,2R,5S)-
Lepetegravir
lepetegravir [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LEPETEGRAVIR

Synonyms and Mappings

Resources